Paracetamol is one of 316 small molecule programs targeting Analgesic Efficacy. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
744 competitors in Breast Cancer
Paracetamol
Adenocard
Lexiscan
Methylthioninium Chloride
Duragesic
Sporanox
Vfend
Neoadjuvant Treatment
Tianeptine
Diuretic
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources